BeStock  
Stocks › Biotechnology › DYN

Dyne Therapeutics DYN

US equityMarket cap rank #2457Biotechnology
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–

DYN Stock News

Headlines matching Dyne Therapeutics or the DYN ticker, most recent first.

  • A Quick Look at Today's Ratings for Dyne Therapeutics(DYN.US), With a Forecast Between $26 to $50Market news · 9 Sep 2026 · Direct mention
  • Jefferies Initiates Dyne Therapeutics(DYN.US) With Buy Rating, Announces Target Price $50Market news · 8 Sep 2026 · Direct mention
  • Stifel Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $37Market news · 30 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $40Market news · 30 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $32 NegativeMarket news · 30 Sep 2026 · Direct mention
  • Piper Sandler Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $47Market news · 29 Sep 2026 · Direct mention
  • Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $37 NegativeMarket news · 24 Sep 2026 · Direct mention
  • J.P. Morgan Downgrades Dyne Therapeutics(DYN.US) to Sell Rating, Announces Target Price $10 NegativeMarket news · 11 Sep 2026 · Direct mention
  • Baird Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $26 NegativeMarket news · 10 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $36 NegativeMarket news · 10 Sep 2026 · Direct mention
  • Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 5 Aug 2026 · Direct mention
  • Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $40Market news · 25 Aug 2026 · Direct mention
  • Walter Dyn: Measures for the Management of Market Capitalization of Shandong Walter Dyn Health Co., Ltd.SZSI · 21 Aug 2026 · Direct mention
  • Walter Dyn: Summary Table of Non-Operating Fund Occupancy and Other Related Party Transactions for the First Half of 2026, Shandong Walter Dyn Health Co., Ltd.SZSI · 21 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $50Market news · 17 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on DYN.

Sign in to join the discussion.

Scroll to Top